Zoliflodacin — Active Pharmaceutical Ingredient

Zoliflodacin is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: FOR SUSPENSION. Routes: ORAL.

This content is for informational purposes only. Always consult a healthcare professional.

Zoliflodacin (1 brand name, 1 dosage form, 1 route)

Available dosage forms: FOR SUSPENSION.

Routes of administration: ORAL.

Brand Names

  • NUZOLVENCE

Contraindications

NUZOLVENCE is contraindicated in: patients with a known history of hypersensitivity to NUZOLVENCE [see Warnings and Precautions (5.4)]. patients who use concomitant moderate or strong CYP3A4 inducers because concomitant use is predicted to result in decreased plasma concentrations of zoliflodacin and may reduce the efficacy of NUZOLVENCE [see Drug Interactions (7.1) and Clinical Pharmacology (12.3)].

Adverse Reactions

The following clinically significant adverse reactions are discussed in the Warnings and Precautions section of the labeling: Hypersensitivity Reactions [see Warnings and Precautions (5.4)]

Mechanism of Action

NUZOLVENCE is an antibacterial drug [see Microbiology (12.4)].

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.